NCT01366391View on ClinicalTrials.gov

Therapeutic Monitoring of Metformin in Women With Polycystic Ovary Syndrome

PHASE4UnknownINTERVENTIONAL

Enrollment

24

Participants

Timeline

Start Date

January 31, 2011

Primary Completion Date

August 31, 2011

Study Completion Date

October 31, 2011

Conditions

Polycystic Ovary Syndrome

Interventions

DRUG

Metformin

Metformin 500 mg tablet (1000 or 1500 mg/day)

Trial Locations (1)

85903-590

RECRUITING

Biocinese, Toledo

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Biocinese

INDUSTRY